Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pierre Ellul

Showing results (161-170 of 167) with videos related to

Pageof 17
Sort By:
You have reached the last page of results.This site can display upto 167 results.
Journal of Crohn'S & Colitis|October 6, 2018
Natural Disease Course of Ulcerative Colitis During the First Five Years of Follow-up in a European Population-based Inception Cohort-An Epi-IBD StudyJohan Burisch, Konstantinos H Katsanos, Dimitrios K Christodoulou, et al.
Journal of Crohn'S & Colitis|October 22, 2024
Post-Discharge Outcomes of Elderly Patients Hospitalized for Inflammatory Bowel Disease Flare Complicated by Clostridioides difficile InfectionIdan Goren, Ortal Fallek Boldes, Tomer Boldes, et al.
Journal of Crohn'S & Colitis|July 1, 2026
ECCO Guidelines on Therapeutics in Ulcerative Colitis: Surgical TreatmentMichel Adamina, Peter Kienle, María Chaparro, et al.
The Lancet. Gastroenterology & Hepatology|February 17, 2020
Health-care costs of inflammatory bowel disease in a pan-European, community-based, inception cohort during 5 years of follow-up: a population-based studyJohan Burisch, Hillel Vardi, Doron Schwartz, et al.
Human Molecular Genetics|February 8, 2021
Transethnic analysis of the human leukocyte antigen region for ulcerative colitis reveals not only shared but also ethnicity-specific disease associationsFrauke Degenhardt, Gabriele Mayr, Mareike Wendorff, et al.
JAMA|February 27, 2019
Association of Genetic Variants in NUDT15 With Thiopurine-Induced Myelosuppression in Patients With Inflammatory Bowel DiseaseGareth J Walker, James W Harrison, Graham A Heap, et al.
Journal of Crohn'S & Colitis|July 27, 2022
Endoscopic Postoperative Recurrence in Crohn's Disease After Curative Ileocecal Resection with Early Prophylaxis by Anti-TNF, Vedolizumab or Ustekinumab: A Real-World Multicentre European StudyHenit Yanai, Anna Kagramanova, Oleg Knyazev, et al.
Pageof 17

Showing results (161-170 of 167) with videos related to

Sort By:
Pageof 17
You have reached the last page of results.This site can display upto 167 results.
Journal of Crohn'S & Colitis|October 6, 2018
Natural Disease Course of Ulcerative Colitis During the First Five Years of Follow-up in a European Population-based Inception Cohort-An Epi-IBD StudyJohan Burisch, Konstantinos H Katsanos, Dimitrios K Christodoulou, et al.
Journal of Crohn'S & Colitis|October 22, 2024
Post-Discharge Outcomes of Elderly Patients Hospitalized for Inflammatory Bowel Disease Flare Complicated by Clostridioides difficile InfectionIdan Goren, Ortal Fallek Boldes, Tomer Boldes, et al.
Journal of Crohn'S & Colitis|July 1, 2026
ECCO Guidelines on Therapeutics in Ulcerative Colitis: Surgical TreatmentMichel Adamina, Peter Kienle, María Chaparro, et al.
The Lancet. Gastroenterology & Hepatology|February 17, 2020
Health-care costs of inflammatory bowel disease in a pan-European, community-based, inception cohort during 5 years of follow-up: a population-based studyJohan Burisch, Hillel Vardi, Doron Schwartz, et al.
Human Molecular Genetics|February 8, 2021
Transethnic analysis of the human leukocyte antigen region for ulcerative colitis reveals not only shared but also ethnicity-specific disease associationsFrauke Degenhardt, Gabriele Mayr, Mareike Wendorff, et al.
JAMA|February 27, 2019
Association of Genetic Variants in NUDT15 With Thiopurine-Induced Myelosuppression in Patients With Inflammatory Bowel DiseaseGareth J Walker, James W Harrison, Graham A Heap, et al.
Journal of Crohn'S & Colitis|July 27, 2022
Endoscopic Postoperative Recurrence in Crohn's Disease After Curative Ileocecal Resection with Early Prophylaxis by Anti-TNF, Vedolizumab or Ustekinumab: A Real-World Multicentre European StudyHenit Yanai, Anna Kagramanova, Oleg Knyazev, et al.
Pageof 17